Astellas Pharma Inc.

4503 TSE Pharmaceuticals Pharmaceutical
TSE Prime
¥2,240.50
+0.61%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

✓Strengths

  • Moderate debt: debt-to-equity of 0.95.
  • Comfortable interest cover: operating profit covers interest about 27.2 times.
  • Return on equity is healthy at 17.4%.
  • Return on capital employed is moderate at 13.4%.
  • Net profit margin is 13.6%.
  • Current assets comfortably cover current liabilities (current ratio 1.98).
  • Profit has compounded about 24% a year over five years.
  • Sales have compounded about 13% a year over five years.
  • Has paid a dividend in each of the last 5 years on record.

!Watch-points

No notable watch-points flagged by the automated checks.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
1.55

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreModerate
5 / 5

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 5 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap¥4兆 172億
Current Price¥ 2,240.50
High / Low¥ 2,717.00 / 1,557.50
Stock P/E13.812342
Book Value¥ 892.92
Dividend Yield3.5%
ROCE13.43%
ROE17.40%
Debt to Equity0.95
Current Ratio1.98
P/B Ratio2.0678835
EPS¥ 162.77
PAT Margin13.63%
ICR27.19
Compounded Sales Growth
10 Years —
5 Years 13.34%
3 Years —
TTM —
Compounded Profit Growth
10 Years —
5 Years 23.81%
3 Years —
TTM —
Stock Price CAGR
10 Years —
5 Years —
3 Years —
1 Year —
Return on Equity
10 Years —
5 Years —
3 Years —
Last Year 17.40%
Educational data only. Not a recommendation to buy, sell or hold any security.